New research has indicated that people who are exposed to very low levels of sunlight and who also have a history of having a common virus known as mononucleosis, are at greater odds of developing multiple sclerosis (MS) than those without the virus.
Continue reading ‘Low Sunlight Exposure and Common Virus Responsible for Multiple Sclerosis’
After many days of openly denying the “existence and public health importance” of the NDM-1 gene, India has finally agreed to search for the presence of superbugs in the Capital and its water supply lines.Quietly yielding under pressure, the National Centre for Disease Control (NCDC) has agreed to lead a study to detect the “prevalence of Carbapenem resistance in Delhi’s ICUs and environment”. Carbapenems are the most powerful generation of antibiotics.
Researchers worldwide are hailing a new discovery as being a possible breakthrough in the treatment for AIDS. Scientists have developed a new protein that stops the AIDS the virus from entering cells. This protein has a basic make-up of naturally occurring proteins in the body that protects cells from viruses, except the human-made version does not cause inflammation and other side effects at the dosages needed to inhibit AIDS.
While it might seem unbelievable, MIT engineers have announced that they have managed to design a new type of nanoparticles that could effectively and safely deliver vaccines for diseases such as malaria and HIV. HIV is known to be one of the biggest killers in the world and till now no one has been able to successfully create a vaccine for combating this deadly virus.
Continue reading ‘New Nanoparticles from MIT could lead to Vaccines for HIV, Malaria and Others’
Studying how bacteria incorporate foreign DNA from invading viruses into their own regulatory processes, Thomas Wood, professor in the Artie McFerrin Department of Chemical Engineering at Texas A&M University, is uncovering the secrets of one of nature’s most primitive immune systems.
Continue reading ‘Bacteria Provide Example of One of Nature’s First Immune Systems’
Recent data presented to the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Children’s Vaccines has revealed some shocking information about the effects of the H1N1 / swine flu vaccine on pregnant women. According to the National Coalition of Organized Women, the rate of miscarriage among pregnant women during the 2009 H1N1 / swine flu pandemic soared by over 700 percent compared to previous years, pointing directly to the vaccine as the culprit — but the CDC denies the truth and continues to insist nobody has been harmed.
Continue reading ‘H1N1 Vaccine Linked to 700% Increase in Miscarriages?’
Studies of the spinal fluid of patients given anti-HIV drugs have resulted in new findings suggesting that the brain can act as a hiding place for the HIV virus. Around 10% of patients showed traces of the virus in their spinal fluid but not in their blood — a larger proportion than previously realized, reveals a thesis from the University of Gothenburg, Sweden.
Continue reading ‘HIV Virus Hides in the Brain, Swedish Study Finds’
Brian Orelli of The Motley Fool highlights four drugs–AstraZeneca’s Brilinta, Questcor’s Acthar Gel, Savient’s Krystexxa and Novartis’ Gilenia–that could gain FDA approval this month despite some previous difficulties. However, given recent troubles with other approved drugs, the FDA’s cautious nature could cause issues for some of the drugmakers.
Continue reading ‘Four Drugs Look to Pass FDA Muster this Month’
Critical challenges remain in the centuries-old battles against infectious diseases, particularly as bacteria and viruses mutate and as the threat of bioterrorism grows. Responding to this need, America’s biopharmaceutical research companies this year have 395 new medicines and vaccines in the pipeline to fight infectious diseases. All 395 are in later stages of development, meaning in clinical trials or under Food and Drug Administration (FDA) review.
Continue reading ‘Nearly 400 Medicines and Vaccines in Development to Fight Infectious Diseases’
A leaky product development pipeline is hampering the country’s ability to ensure a steady output of new medical countermeasures, such as medications, vaccines, equipment and supplies needed for health emergencies, HHS Secretary Kathleen Sebelius said.
Continue reading ‘Feds Aim to Fortify Biodefense by Fixing Product Development Pipeline’
You are currently browsing the weblog archives for the Virus category.
Biotech Trading Signals Pharma News Biotech News